Sentence examples for target rely on from inspiring English sources
And both bidders, smaller than their target, rely on bank debt to finance the acquisition.Consolidation in the sector has much to recommend it, not least for Orange and for Free, whose share prices rose even more than that of Bouygues the following day.
The background binding of the PET tracer to both the noninflamed knee joint and periarticular bone (marrow) (in both knees and other physiological locations) could lead to underestimation of targeting properties of the applied PET tracer since PET imaging of a target relies on the contrast between the target and its background.
Under real-time OCT guidance (typically with high-speed rotational imaging at one fixed position without automated pull-back), the needle is inserted into tissue toward its target, relying on the radial OCT image data to provide immediate feedback and to differentiate normal from abnormal regions of tissue.
As many of the remaining difficult disease targets rely on varying levels of CMI responses with or without an associated humoral response there is a large unmet need for novel CMI inducing adjuvants.
The presented algorithm is also being integrated in audio-video tracking of multiple targets relying on a Bayesian framework [28].
a Passive targeting relies on the leaky vasculature that is exhibited by tumors, allowing nanoparticles to travel through the fenestrations and reach tumors.
The frequency of germline mutants in G1 was sufficient to be used for gene targeting relying on a screen based solely on molecular methods.
Photoreceptor axon targeting relies on a sequence of interdependent developmental steps to achieve temporal coordination with the formation and maturation of partner neurons.
But the agreement does not contain binding emissions targets, relying on governments to set their own goals.
However, this study preceded the discovery of fluorescent fusion proteins and laser targeting relied on approximation of centrosome location based on phase contrast imaging.
Development of therapies against these targets relies on our ability to pinpoint the exact stage of disease in which proteasome impairment contributes to the pathogenesis.
